Form D — Satellos Bioscience Inc.
0001421642-25-000001 · filed 2025-01-03
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $25,016,264
- Total sold
- $25,016,264
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Satellos Bioscience Inc.
- CIK
- 1421642
- Entity
- Corporation
- Jurisdiction
- CANADA (FEDERAL LEVEL)
- Year incorporated
- 2021
- Address
- ROYAL BANK PLAZA, S. TOWER, 200 BAY ST.
TORONTO, A6 M5J 2J1 - Phone
- 416-708-0522
Related persons
-
Frank Gleeson · Executive OfficerToronto, A6
-
Michael Rudnicki · Executive OfficerToronto, A6
-
Elizabeth Williams · Executive OfficerToronto, A6
-
Geoff MacKay · DirectorToronto, A6
-
Adam Mostafa · DirectorToronto, A6
-
Brian Bloom · DirectorToronto, A6
-
William McVicar · DirectorToronto, A6
-
Bill Jarosz · DirectorToronto, A6
-
Rima Al-awar · DirectorToronto, A6
-
Michael Robert Cross · Executive OfficerToronto, A6
-
Philip D. Lambert · Executive OfficerToronto, A6
-
Courtney Wells · Executive OfficerToronto, A6
-
Franklin Berger · DirectorToronto, A6
-
Stephanie Brown · DirectorToronto, A6
View original on SEC EDGAR.